Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 9/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 7/20 | 1.00 |
| ▸ | MAOA | P21397 | 1/20 | 1.00 |
| ▸ | PSMB5 | P28074 | 1/20 | 1.00 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.86 |
| ▸ | TUBB | P07437 | 1/20 | 0.86 |
| ▸ | YES1 | P07947 | 1/20 | 0.86 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.86 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.86 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.86 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.86 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.86 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.86 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.86 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.86 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.86 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.86 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.86 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.86 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 7-Hydroxyflavanone SCHEMBL29843931 | 1.00 | MAOB (1.00) | MAOBCYP19A1MAOAPSMB5TUBB4A | |
| 7-Hydroxyflavanone SCHEMBL1072683 | 1.00 | MAOB (1.00) | MAOBCYP19A1MAOAPSMB5TUBB4A | |
| 7-Hydroxyflavanone SCHEMBL130266 | 1.00 | MAOB (1.00) | MAOBCYP19A1MAOAPSMB5TUBB4A | |
| Liquirtigenin SCHEMBL3120177 | 0.93 | MAOB (0.87) | MAOBCYP19A1MAOAPSMB5TUBB4A | |
| Liquirtigenin SCHEMBL1071066 | 0.92 | CYP19A1 (1.00) | MAOBCYP19A1MAOAPSMB5TUBB4A | |
| Liquirtigenin SCHEMBL26970367 | 0.92 | CYP19A1 (1.00) | MAOBCYP19A1MAOAPSMB5TUBB4A | |
| Liquirtigenin SCHEMBL74552 | 0.92 | CYP19A1 (1.00) | MAOBCYP19A1MAOAPSMB5TUBB4A | |
| Liquirtigenin SCHEMBL29552383 | 0.92 | CYP19A1 (1.00) | MAOBCYP19A1MAOAPSMB5TUBB4A | |
| Liquirtigenin SCHEMBL30352791 | 0.92 | CYP19A1 (1.00) | MAOBCYP19A1MAOAPSMB5TUBB4A | |
| Liquirtigenin SCHEMBL4649862 | 0.91 | CYP19A1 (0.97) | MAOBCYP19A1MAOAPSMB5TUBB4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 324 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117338835-A | Preparation method of medicine tablet for treating osteoporosis | 广西十万山制药有限公司 | 2024-01-05 | — | — | CN | claimed |
| US-20260033492-A1 | Pest Repellents and Uses Thereof | SENSORYGEN INC (US) | 2026-02-05 | — | — | US | disclosed |
| CN-120078040-A | Preparation method of corn flour for corn cauterization production | 巢湖美维食品有限公司 | 2025-06-03 | — | — | CN | disclosed |
| US-12280129-B2 | Compositions and methods for improved skin care | PINSKY MARK A (US) | 2025-04-22 | — | — | US | disclosed |
| US-12156832-B2 | Method, and system for multi-layer cosmetic pads and use thereof | ELC MANAGEMENT LLC (US) | 2024-12-03 | — | — | US | disclosed |
| CN-118496516-B | Dichlorobenzene bisureido-beta-cyclodextrin stationary phase and preparation method and application thereof | 南昌大学 | 2024-09-20 | — | — | CN | disclosed |
| CN-118496516-A | Dichlorobenzene bisureido-beta-cyclodextrin stationary phase and preparation method and application thereof | 南昌大学 | 2024-08-16 | — | — | CN | disclosed |
| CN-117338835-A | Preparation method of medicine tablet for treating osteoporosis | 广西十万山制药有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-115569643-B | Method for preparing chiral separation material by vacuum-assisted solid phase reaction bonding | 宁波大学 | 2023-10-03 | — | — | CN | disclosed |
| US-20230292754-A1 | Pest Repellents and Uses Thereof | UNIVERSITY OF CALIFORNIA RIVERSIDE | 2023-09-21 | — | — | US | disclosed |
| WO-2000062745-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000062743-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000062742-A2 | METHODS FOR REGULATING THE CONDITION OF MAMMALIAN KERATINOUS TISSUE | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000062740-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000062741-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
| WO-2000062744-A2 | SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-26 | — | — | WO | disclosed |
| US-6093411-A | AN EMULSION COMPRISING FLAVONOIDS FOR PREVENTING OR TREATING SKIN DISORDERS | THE PROCTER & GAMBLE COMPANY (US) | 2000-07-25 | — | — | US | disclosed |
| US-6051602-A | METHODS FOR PREVENTION OR TREATING SKIN DISORDERS USING FLAVONOID COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2000-04-18 | — | — | US | disclosed |
| WO-1999047118-A1 | COMPOSITIONS FOR REGULATING SKIN APPEARANCE | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-23 | — | — | WO | disclosed |
| WO-1999047113-A1 | COMPOSITIONS FOR REGULATING SKIN APPEARANCE | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260033492-A1 | Pest Repellents and Uses Thereof | F3, TFPI, FLI1 | MAOB 1790/4885CYP19A1 2958/4885MAOA 602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.